Inverse Emulsion Polymerization-based Glycol Nanohydrogel Development Service
Overview
Inverse emulsion polymerization has become a key tool for the preparation of functional biomaterials such as glycol nanohydrogel by synthesizing high molecular weight water-soluble polymers efficiently. The nanohydrogel prepared by this technique has attracted a wide range of scientific and industrial attention due to its great potential for applications in a variety of fields such as biomedical research, agricultural production, and tissue engineering. As a pioneer in the field of nanomaterials research and development, CD BioGlyco specializes in the development of glycol nanohydrogel by inverse emulsion polymerization and other technologies and has built up a well-established GlycoNano™ Platform. Based on this strong foundation, we offer a one-stop inverse emulsion polymerization-based glycol nanohydrogel development service from conceptual design to product realization. Our goal is to accelerate the development process, deepening scientific research, and exploring a wider range of applications to facilitate scientific research and industrial translation.
Precision Glycol Nanohydrogel Development: Empowered by Advanced Technology
Leveraging our extensive expertise, we facilitate accelerated research, optimize the formulation process of glycol nanohydrogels, and provide insightful guidance for the design and application of your products. Combined with our extensive experience in glycol nanohydrogel development, specific service processes include the following:
Advantages of Inverse Emulsion Polymerization
An emulsifier facilitates the formation of a water-in-oil emulsion, which subsequently undergoes polymerization of the monomer and crosslinking agent to produce a glycol nanohydrogel. Inverse emulsion polymerization distinguishes itself from other methods by exhibiting fewer side reactions, a quicker polymerization rate, and gentler reaction conditions. Moreover, its smaller emulsion particle size minimizes the thermal impact of the polymerization reaction, enabling easier temperature control. As a result, this technique finds versatile applications in diverse polymerization reaction systems.
Inverse Emulsion Polymerization-based Glycol Nanohydrogel Development
A detailed experimental procedure is carefully tailored and the glycol nanohydrogel prepared by inverse emulsion polymerization is fully characterized. Various factors affecting the inverse emulsion polymerization are considered and optimized to ensure the high quality of the final product, including the stability of the emulsion system (emulsifier concentration, type of oil phase, pH, HLB value), monomer concentration, initiator concentration, temperature, and oil-to-water ratio. Experienced laboratory personnel and quality monitoring systems ensure that the entire process is carried out efficiently.
- Design of Glycol Nanohydrogel
Based on the diversity of natural and synthetic polymer backbone structures and functional groups, we customize a variety of glycol nanohydrogels to meet specific application requirements. The effects of preparation and purification conditions on nanoparticle composition, morphology, and properties are analyzed in detail to accelerate the development of nanomaterials suitable for various applications. - Preparation of Glycol Nanohydrogel
We perform a systematic analysis of the effects of polymerization and purification conditions on the composition, morphology, and properties of glycol nanohydrogel to accelerate the development of materials for a range of applications. A variety of factors influence the preparation of glycol nanohydrogel. For example, monomer concentration primarily affects the reaction rate and molecular weight of the polymerization product. The concentration of the emulsifier is a key factor in the stabilization of the inverse emulsion. Temperature mainly affects the efficiency of molecular movement. We optimize the inverse emulsion polymerization process to produce high-quality nanohydrogels. -
Characterization of Glycol Nanohydrogel
This process involves the characterization of the Physicochemical Properties of the glycol nanohydrogel (particle size analysis, morphology observation, functional group analysis, mechanical property assessment, etc.) and Molecular Interaction Analysis. We provide comprehensive characterization services using the following technologies:- Dynamic light scattering (DLS) is used for particle size distribution and binding affinity analysis.
- Transmission electron microscope (TEM)and scanning electron microscopy (SEM) are used for morphological analysis.
- Fourier transform infrared spectroscopy (FTIR) is used to confirm the functional groups of glycol nanohydrogel.
- Other analytical techniques such as nuclear magnetic resonance (NMR), surface plasmon resonance (SPR), and X-ray photoelectron spectroscopy(XPS) are used to characterize the glycol nanohydrogel.
Workflow
We are the first to discuss project goals, requirements, and timelines with our clients. After evaluating the technical feasibility and developing a solution, we carry out the preparation and detailed characterization of the glycol nanohydrogel.

Applications
- Biomedical applications: Glycol nanohydrogel based on inverse emulsion polymerization is used for targeted controlled release of drugs to improve therapeutic efficacy.
- Cosmetic applications: Glycol nanohydrogel based on inverse emulsion polymerization is used to encapsulate moisturizers and other active molecules in skin care formulations to enhance product efficacy.
- Agricultural applications: Glycol nanohydrogel developed based on inverse emulsion polymerization is used in controlled-release fertilizers and pesticides.
Advantages
- Our team consists of researchers experienced in glycol nanohydrogel development and specializing in polymer science and materials development.
- We use state-of-the-art technologies and methods in the synthesis and characterization of glycol nanohydrogel.
- We offer customizable glycol nanohydrogel development service packages to meet varying client needs and project complexities.
Publication Data
Technology: Precipitation polymerization, inverse mini-emulsion polymerization
Journal: International Journal of Molecular Sciences
IF: 4.556
Published: 2022
Results: This review describes the design and wide range of applications of nanohydrogels including glycol nanohydrogels. Isolated polymers of natural origin and synthetic polymers were constructed by different strategies such as ionic interactions and cross-linking. Depending on the material, build assembly, and functionalization, nanohydrogel can be classified as chondroitin-based nanohydrogel, branched starch-based nanohydrogel, chitosan-based nanohydrogel, and so on. The preparation methods include inverse microemulsion polymerization methods, precipitation polymerization methods, and so on. These nanohydrogels have a wide range of applications in agriculture, biomedicine, etc.
Frequently Asked Questions
- What are the advantages of glycol nanohydrogel developed using inverse emulsion polymerization?
- Biocompatible: They are generally well-biocompatible and suitable for biological applications.
- Controlled release: They can be designed to release the encapsulated substance at a controlled rate.
- Wide range of applications: They are suitable for pharmaceutical, cosmetic, and agricultural applications.
- How long does the formulation process take?
Depending on the complexity and specific requirements of the project, glycol nanohydrogel development may vary. In general, the overall development process ranges from a few weeks to a few months, depending on condition optimization and characterization.
CD BioGlyco provides a market-competitive glycol nanohydrogel development service based on inverse emulsion polymerization to clients worldwide. If you have any questions about this service, please feel free to contact us directly by e-mail or through our website. Let us help you innovate and achieve your project goals in the rapidly evolving field of nanotechnology.
Reference
- Quazi, M.Z.; Park, N. Nanohydrogels: advanced polymeric nanomaterials in the era of nanotechnology for robust functionalization and cumulative applications. International Journal of Molecular Sciences. 2022, 23(4): 1943.
Quick Links
Resources
- Glyco™ Synthesis Platform
- Custom Glycoprotein Synthesis
- Custom Glycoside Synthesis
- Custom Glycosyl Donor Synthesis
- Custom Thioglycoside Synthesis
- Custom Phosphatidylinositol Synthesis
- Custom Cyclodextrin Synthesis
- Custom Rhamnolipid Synthesis
- Custom Sphingolipid Synthesis
- Custom Building Block Synthesis
- Carbohydrate Manufacturing
- Synthesis Process Development and Optimization
- Custom Carbohydrate Synthesis
- Custom Glycolipid Synthesis
- Custom Glycopeptide Synthesis
- Custom Glycoconjugate Synthesis
- Custom Sugar-Nucleotide Synthesis
- Nucleoside & Nucleotide Synthesis Service
- Custom Oligonucleotide Synthesis Service
- Polynucleotide Synthesis Service
- Nucleoside & Nucleotide Modification Service
- Oligonucleotide Modification Service
- Nucleoside-based Production Service
- Nucleotide-based Production Service
- OPME-based NDP-sugar Synthesis Service
- OPME-based NMP-sugar Synthesis Service
- Glycomics Platform
- Glycoproteomics Platform
- N-Glycoproteomics of PDX Models
- Nanotechnologies for the Detection of Glycopeptides
- Glycoprotein Enrichment
- Glycoprotein Quantification
- Glyco-biomarker Detection Service
- Glyco-biomarker AFP Detection Service
- Glyco-biomarker CA19-9 Detection Service
- Glyco-biomarker CA125 Detection Service
- Glyco-biomarker CA15–3 Detection Service
- Glyco-biomarker CEA Detection Service
- Glyco-biomarker PSA Detection Service
- Glyco-biomarker Immunoglobulin G (IgG) Detection Service
- Glyco-biomarker Haptoglobin (Hp) Detection Service
- Glyco-biomarker α1-Antitrypsin (A1AT) Detection Service
- Glyco-biomarker α1-Acid Glycoprotein (AGP) Detection Service
- Glyco-biomarker Ceruloplasmin (CP) Detection Service
- Glyco-biomarker Fetuin A Detection Service
- Site Occupation
- Glycoprotein Structure Analysis
- Glycosylation Site-specific Antibody-Drug Conjugate (ADC) Development Platform
- Carbohydrate-based Glycomedicine Development Platform
- By Sources of Carbohydrate
- By Types of Carbohydrate
- Monosaccharides-based Glycomedicine Development
- Disaccharides-based Glycomedicine Development
- Trisaccharides-based Glycomedicine Development
- Oligosaccharides-based Glycomedicine Development
- Polysaccharides-based Glycomedicine Development
- Glycosides-based Glycomedicine Development
- Glycopeptide-based Glycomedicine Development
- Glycomimetic-based Glycomedicine Development
- By Applications of-based Glycomedicines
- Carbohydrate-based Anticoagulant Glycomedicine Development
- Carbohydrate-based Cardiovascular Glycomedicine Development
- Carbohydrate-based Antitumor Glycomedicine Development
- Carbohydrate-based Antidiabetic Glycomedicine Development
- Carbohydrate-based Antibacterial Glycomedicine Development
- Carbohydrate-based Antiviral Glycomedicines Development
- Carbohydrate-based Antiparasiti Glycomedicine Development
- By Discovery Strategies
- Glycoengineering-based Glycomedicine Development
- Production of Food Ingredients
- Multi-omics Platform for Cancer Glucose Metabolism (MOPCGM)
- Cancer Cell Glycolytic Analysis
- Cancer Cell TCA Cycle Analysis
- Cancer Cell PPP Analysis
- Gene-level Regulation Analysis of Cancer Glucose Metabolism
- Interplay Between Glucose Metabolism Reprogramming and Tumorigenesis & Progression
- Interplay Between Glucose Metabolism Reprogramming and Proliferative Signaling
- Interplay Between Glucose Metabolism Reprogramming and Growth Suppressor
- Interplay Between Glucose Metabolism Reprogramming and Cancer Cell Death
- Interplay Between Glucose Metabolism Reprogramming and Replicative Immortality
- Interplay Between Glucose Metabolism Reprogramming and Angiogenesis
- Interplay Between Glucose Metabolism Reprogramming and Invasion & Metastasis
- Interplay Between Glucose Metabolism Reprogramming and Immune Escape
- Interplay Between Glucose Metabolism Reprogramming and Genomic Instability
- Interplay Between Glucose Metabolism Reprogramming and Tumor-associated Inflammation
- Glucose Metabolism-Microenvironment Crosstalk Analysis in Cancer
- Cancer Glucose Metabolism In Vivo Analysis
- Applications of Studing Cancer Glucose Metabolism
- Discovery of Cancer Glucose Metabolism Small Molecule Inhibitor
- Discovery of Cancer Glucose Metabolism Therapeutic Monoclonal Antibodies
- Development of Gene Therapy Targeting Cancer Glucose Metabolism
- Discovery of Cancer Glucose Metabolism CAR-T Therapy Targeting
- Discovery of Cancer Glucose Metabolism Combination Therapy Strategy
- Discovery of Cancer Glucose Metabolism Precision Therapeutic Strategies
- Glycoengineering Platform
- Therapeutic Nucleic Acid Development Platform
- Therapeutic Oligonucleotide Synthesis Service
- siRNA Synthesis
- miRNA Synthesis
- ASO Synthesis
- Aptamer Synthesis
- PMO Synthesis
- sgRNA Synthesis
- Circular RNA Synthesis
- PNA Synthesis
- Lipid-based GalNac-RNA Delivery Service
- CpG Oligonucleotide Synthesis
- Click-based GalNac-RNA Delivery Service
- AntimiR Synthesis
- GalNAc-siRNA Delivery Service
- tRNA Synthesis
- GalNAc-ASO Delivery Service
- saRNA Synthesis
- Reporter Gene mRNA Synthesis
- Gene Editing mRNA Synthesis
- Gene Replacement mRNA Synthesis
- Cre Recombinase mRNA Synthesis
- hEPO mRNA Synthesis
- OVA mRNA Synthesis
- Therapeutic Oligonucleotide Modification Service
- Therapeutic Oligonucleotide Delivery Development Service
- Targeted Ligand and Linker Synthesis
- Monoantennary GalNac-RNA Delivery
- Biantennary GalNac-RNA Delivery
- Triantennary GalNac-RNA Delivery
- Tetra-antennary GalNac-RNA Delivery
- Solution Phase-based GalNac-RNA Delivery
- Solid Phase-based GalNac-RNA Delivery
- mRNA Poly(A) Tail Length Analysis
- GalNAc-siRNA Delivery
- GalNAc-ASO Delivery
- GalNAc-miRNA Delivery
- GalNAc-Aptamer Delivery
- GalNAc-AntimiR Delivery
- GalNAc-mRNA Delivery
- GalNAc-PNA Delivery
- Peptide-Therapeutic Oligonucleotide Delivery
- LNP-Therapeutic Oligonucleotide Delivery
- PEG-Therapeutic Oligonucleotide Delivery
- Biological Evaluation Service for Therapeutic Oligonucleotide
- mRNA-based Vaccine Development Service
- mRNA Sequence Design&Optimization Service
- mRNA Integrity Analysis ServicemRNA Integrity Analysis Service
- mRNA Biodistribution Analysis Service
- DNA Template Preparation Service
- mRNA Purity Analysis Service
- T Cell Cytokine Secretion Analysis Service
- mRNA Modification Service
- mRNA Length Analysis Service
- mRNA Purification Service
- Neutralizing Antibody Assay Service
- mRNA-LNP Formulation and Encapsulation Service
- mRNA Structural Characterization
- mRNA Structural Characterization Service
- mRNA Bioanalysis Service
- mRNA Residual DNA Template Analysis Service
- mRNA Residual Double-Stranded RNA (dsRNA) Analysis Service
- mRNA Size Analysis Service
- mRNA Polydispersity Analysis Service
- mRNA Zeta Potential Analysis Service
- mRNA Lipid Composition Analysis Service
- Oligonucleotide Drug Process and Formulation Development Service
- RNA Drug Process and Formulation Development
- Therapeutic Oligonucleotide Synthesis Service
- Glycobiology Microarray Platform
- Glyco™ Vaccine Development Platform
- Carbohydrate-based Vaccine Development
- Polysaccharide Vaccine Development
- Tumor-Associated Carbohydrate Vaccine Development
- Glycoconjugate Vaccine Development
- Natural Carbohydrate-based Vaccine Development
- Semi-synthetic Carbohydrate-based Vaccine Development
- Fully Synthetic Carbohydrate-based Vaccine Development
- Carbohydrate-based Antibacterial Vaccine Development
- Carbohydrate-based Antifungal Vaccine Development
- Carbohydrate-based Antiparasitic Vaccine Development
- Carbohydrate-based Antiviral Vaccine Development
- Carbohydrate-based Anticancer Vaccine Development
- Carbohydrate-based Antihelmintic Vaccine Development
- Monovalent Carbohydrate-based Vaccine Development
- Polyvalent Carbohydrate-based Vaccine Development
- Carrier Protein Design Service
- Carbohydrate Conjugation Service for Vaccine Development
- Carbohydrate-based Adjuvant Development
- Lipopolysaccharide-based Adjuvant Development
- Bacterial Outer Membrane Vesicles (OMVs)-based Adjuvant Development
- Trehalose Glycolipid-based Adjuvant Development
- Galactosylceramide-based Adjuvant Development
- Peptidoglycan-based Adjuvant Development
- Chitin/Chitosan-based Adjuvant Development
- Inulin-based Adjuvant Development
- Mannans-based Adjuvant Development
- Alginate-based Adjuvant Development
- Saponin-based Adjuvant Development
- α-Glucan-based Adjuvant Development
- Lentinan-based Adjuvant Development
- β-Glucans-based Adjuvant Development
- Deltin-based Adjuvant Development
- Muramyldipeptide-based Adjuvant Development
- Cord Factor-based Adjuvant Development
- Zwitterionic Polysaccharide-based Adjuvant Development
- Novel Plant Polysaccharides-based Adjuvant Development
- Glycoprotein-based Vaccine Development
- Glycopeptide-based Vaccine Development
- Carbohydrate-based Vaccine Development
- Glycogenomics Platform
- Glycogene Editing Service
- Glycogene Delivery Service
- Glycogene Expression Profiling
- Cancer Glycogene Discovery Service
- Glycogene Discovery Service in Cervical Cancer
- Glycogene Discovery Service in Leukemia
- Glycogene Discovery Service in Bladder Cancer
- Glycogene Discovery Service in Colorectal Adenocarcinoma
- Glycogene Discovery Service in Liver Cancer
- Glycogene Discovery Service in Lymphoma
- Glycogene Discovery Service in Breast Cancer
- Glycogene Discovery Service in Prostate Cancer
- Glycogene Discovery Service in Pancreatic Cancer
- Glycogene Discovery Service in Lung Cancer
- Glycogene Discovery Service in Thyroid Cancer
- Glycogene Discovery Service in Ovarian Cancer
- Glycan Display Platform
- Traditional Glycan Display Array
- Natural Oligosaccharide Library Construction Service
- Chemical Synthesis-based Oligosaccharide Library Construction Service
- Enzymatic Synthesis-based Oligosaccharide Library Construction Service
- Modular Synthesis-based Oligosaccharide Library Construction Service
- Oligosaccharide Library Immobilization Service
- Cell-based Glycan Display Array
- Neoglycolipid (NGL) Display Array
- Liquid Glycan Display Array (LiGA)
- Glycophage Display
- N-linked Glycoprotein-based Glycophage Display System Construction Service
- O-linked Glycoprotein-based Glycophage Display System Construction Service
- Glycophage Display-based Glycosylase Genetic Analysis Service
- Glycophag Display-based Glycoarray Service
- Glycophage Display-based Antibody Development Service
- Glycophage Display-based Epitope Mapping Service
- Glycophage Display-based Biomarker Development Service
- De Novo Glycan Display
- Cell-Surface Glycan Editing
- Examining the Effects of Altering Blood Group Antigens on Erythrocyte Cell Surfaces
- Preventing Cellular Rejection During Transplantation
- Modulating Chemical Composition and Physical Parameters of Glycocalyx
- Tailoring Cell Membranes with Biologically Active Glycans
- Targeting Glycosaminoglycan-mediated Growth Factor Signaling to Influence Stem Cell Specification
- Long-term De Novo Glycan Display for Directing Stem Cell Fate
- Traditional Glycan Display Array
- GlycoNano™ Platform
- Glyconanoparticle Development Service
- Techniques for Glyconanoparticle Development
- Carbohydrate-based Nanoparticle Production
- Gold Glyconanoparticle Production
- Silver Glyconanoparticle
- Magnetic Glyconanoparticle
- Quantum Dot (QD) Glyconanoparticle
- Glyconanoparticle Characterization
- PEG Glyconanoparticle
- Carbon-based Glyconanoparticle
- Fluorescent Glyconanoparticle
- Silica Glyconanoparticle
- Liposome Glyconanoparticle
- Glycol Nanohydrogel Development
- Glycol Nanorod
- Glycol Nanotube
- Glycol Nanocrystal/Nanosheet/Nanosphere/Nanofiber
- Glyconanoparticle Preclinical Study
- Glyconanoparticle Formulation
- Glyconanotechnology-based Biosensor Development
- GlycoNano™ Bioink Production for 3D Printing
- Glyconanoparticle Development Service
- Glyco™ Synthesis Platform




